Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.61 |
| ▸ | CA2 | P00918 | 3/20 | 0.61 |
| ▸ | TGM2 | P21980 | 1/20 | 0.55 |
| ▸ | PGR | P06401 | 1/20 | 0.49 |
| ▸ | FKBP1A | P62942 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | IDO1 | P14902 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 4/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.45 |
| ▸ | MMP1 | P03956 | 1/20 | 0.45 |
| ▸ | MMP2 | P08253 | 1/20 | 0.45 |
| ▸ | MMP9 | P14780 | 1/20 | 0.45 |
| ▸ | MMP8 | P22894 | 1/20 | 0.45 |
| ▸ | MMP13 | P45452 | 1/20 | 0.45 |
| ▸ | PKM | P14618 | 2/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.42 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.42 |
| ▸ | PTPRB | P23467 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27183211 | 0.98 | CA1 (0.59) | CA1CA2TGM2PGRFKBP1A | |
| SCHEMBL4455223 | 0.87 | PTPRB (0.48) | CA1CA2MEN1KMT2APKM | |
| SCHEMBL4591628 | 0.78 | CA1 (0.64) | CA1CA2POLBMEN1KMT2A | |
| SCHEMBL3041175 | 0.76 | CA1 (0.52) | CA1CA2IDO1MEN1KMT2A | |
| SCHEMBL7863309 | 0.76 | PTPRB (0.42) | CA1CA2CA12CA9PTPRB | |
| SCHEMBL7258179 | 0.76 | CA1 (0.61) | CA1CA2PGRFKBP1AMEN1 | |
| SCHEMBL27182660 | 0.76 | PTPRB (0.42) | CA1CA2CA12CA9PTPRB | |
| SCHEMBL3365049 | 0.76 | CA1 (0.61) | CA1CA2TGM2PGRFKBP1A | |
| SCHEMBL3088460 | 0.76 | CA1 (0.61) | CA1CA2PGRMEN1KMT2A | |
| SCHEMBL1230858 | 0.76 | KEAP1 (0.53) | CA1CA2POLBMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010017405-A1 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF PAIN | HELLER ADAM (US) | 2010-02-11 | — | — | WO | claimed |
| US-20240332617-A1 | COMPOSITION PRODUCTION METHOD AND NON-AQUEOUS ELECTROLYTE SOLUTION | NIPPON SHOKUBAI CO., LTD. (JP) | 2024-10-03 | — | — | US | disclosed |
| CN-113841280-B | Electrolyte composition, solvent composition, nonaqueous electrolyte solution, and use thereof | 株式会社日本触媒 | 2024-08-09 | — | — | CN | disclosed |
| CN-117480114-A | Method for purifying aqueous sulfonimide solution, method for producing nonaqueous electrolyte solution, and method for producing electrolyte composition | 株式会社日本触媒 | 2024-01-30 | — | — | CN | disclosed |
| CN-117480659-A | Method for producing composition and nonaqueous electrolyte | 株式会社日本触媒 | 2024-01-30 | — | — | CN | disclosed |
| WO-2023242845-A1 | SULFAMATE BASED COVALENT LIGAND-DIRECTED RELEASE (CoLDR) COMPOUNDS | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2023-12-21 | — | — | WO | disclosed |
| US-20230406837-A1 | SULFAMATE MODULATORS OF PIN1 ACTIVITY AND USES THEREOF | YEDA RESEARCH AND DEVELOPMENT CO., LTD. (IL) | 2023-12-21 | — | — | US | disclosed |
| CN-115088112-A | Composition, electrolyte material, and electrolyte | 株式会社日本触媒 | 2022-09-20 | — | — | CN | disclosed |
| WO-2010017405-A1 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF PAIN | HELLER ADAM (US) | 2010-02-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230406837-A1 | SULFAMATE MODULATORS OF PIN1 ACTIVITY AND USES THEREOF | PIN1, PSTPIP2, PIN4 | CA1 765/4885CA2 1952/4885TGM2 2182/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.